Zhanqi Liu
Lanzhou University(CN)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Radiopharmaceutical Chemistry and Applications, CAR-T cell therapy research
Most-Cited Works
- → A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors(2007)217 cited
- → Reduction of precious metal ions in aqueous solutions by contact-electro-catalysis(2024)96 cited
- → Specific Targeting, Biodistribution, and Lack of Immunogenicity of Chimeric Anti-GD3 Monoclonal Antibody KM871 in Patients With Metastatic Melanoma: Results of a Phase I Trial(2001)87 cited
- → An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth(2016)74 cited
- → A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen(2007)73 cited
- A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.(2007)
- → Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a(2018)59 cited
- Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.(2001)
- A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.(2007)
- → One-step green hydrometallurgical recycling of spent lithium-ion batteries’ cathode(2024)32 cited